{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T06:46:43Z","timestamp":1794552403824,"version":"4.9.1"},"publisher-location":"Cham","reference-count":162,"publisher":"Springer International Publishing","isbn-type":[{"value":"9783030695897","type":"print"},{"value":"9783030695903","type":"electronic"}],"license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017]]},"DOI":"10.1007\/10_2017_31","type":"book-chapter","created":{"date-parts":[[2017,11,13]],"date-time":"2017-11-13T10:47:14Z","timestamp":1510570034000},"page":"1-36","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Animal Cell Expression Systems"],"prefix":"10.1007","author":[{"given":"M.","family":"Butler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"U.","family":"Reichl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,10,3]]},"reference":[{"key":"31_CR1","unstructured":"Mordor Intelligence (2016) Global biopharmceuticals market growth, trends and forecasts (2016\u20132021). Mordor Intelligence, Hyderabad"},{"key":"31_CR2","unstructured":"Research and Markets (2013) Biopharmaceuticals \u2013 a global market overview. Research and Markets, Dublin"},{"key":"31_CR3","doi-asserted-by":"publisher","first-page":"568","DOI":"10.4161\/mabs.3.6.17922","volume":"3","author":"K Zheng","year":"2011","unstructured":"Zheng K, Bantog C, Bayer R (2011) The impact of glycosylation on monoclonal antibody conformation and stability. MAbs 3:568\u2013576","journal-title":"MAbs"},{"issue":"Pt 1","key":"31_CR4","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1042\/bj3080009","volume":"308","author":"T Sareneva","year":"1995","unstructured":"Sareneva T, Pirhonen J, Cantell K, Julkunen I (1995) N-glycosylation of human interferon-gamma: glycans at Asn-25 are critical for protease resistance. Biochem J 308(Pt 1):9\u201314","journal-title":"Biochem J"},{"key":"31_CR5","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/j.jbiosc.2013.11.001","volume":"117","author":"M Onitsuka","year":"2013","unstructured":"Onitsuka M, Kawaguchi A, Asano R, Kumagai I, Honda K, Ohtake H, Omasa T (2013) Glycosylation analysis of an aggregated antibody produced by Chinese hamster ovary cells in bioreactor culture. J Biosci Bioeng 117:639\u2013644","journal-title":"J Biosci Bioeng"},{"key":"31_CR6","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1021\/bp049807b","volume":"21","author":"J Rodriguez","year":"2005","unstructured":"Rodriguez J, Spearman M, Huzel N, Butler M (2005) Enhanced production of monomeric interferon-beta by CHO cells through the control of culture conditions. Biotechnol Prog 21:22\u201330","journal-title":"Biotechnol Prog"},{"key":"31_CR7","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/S0167-7799(96)10062-7","volume":"15","author":"A Wright","year":"1997","unstructured":"Wright A, Morrison SL (1997) Effect of glycosylation on antibody function: implications for genetic engineering. Trends Biotechnol 15:26\u201332","journal-title":"Trends Biotechnol"},{"key":"31_CR8","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1056\/NEJMoa074943","volume":"358","author":"CH Chung","year":"2008","unstructured":"Chung CH, Mirakhur B, Chan E, Le QT, Berlin J, Morse M, Murphy BA, Satinover SM, Hosen J, Mauro D, Slebos RJ, Zhou Q, Gold D, Hatley T, Hicklin DJ, Platts-Mills TA (2008) Cetuximab-induced anaphylaxis and IgE specific for galactose-alpha-1,3-galactose. N Engl J Med 358:1109\u20131117","journal-title":"N Engl J Med"},{"key":"31_CR9","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1093\/oxfordjournals.jbchem.a124721","volume":"117","author":"A Noguchi","year":"1995","unstructured":"Noguchi A, Mukuria CJ, Suzuki E, Naiki M (1995) Immunogenicity of N-glycolylneuraminic acid-containing carbohydrate chains of recombinant human erythropoietin expressed in Chinese hamster ovary cells. J Biochem 117:59\u201362","journal-title":"J Biochem"},{"key":"31_CR10","doi-asserted-by":"publisher","first-page":"9","DOI":"10.2165\/11530550-000000000-00000","volume":"24","author":"RJ Sola","year":"2010","unstructured":"Sola RJ, Griebenow K (2010) Glycosylation of therapeutic proteins: an effective strategy to optimize efficacy. BioDrugs 24:9\u201321","journal-title":"BioDrugs"},{"key":"31_CR11","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/nbt0114-6b","volume":"32","author":"M Ratner","year":"2014","unstructured":"Ratner M (2014) Genentech\u2019s glyco-engineered antibody to succeed Rituxan. Nat Biotechnol 32:6\u20137","journal-title":"Nat Biotechnol"},{"key":"31_CR12","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1007\/978-3-319-10320-4_8","volume-title":"Animal cell culture, Cell engineering, vol.9","author":"M Butler","year":"2015","unstructured":"Butler M (2015) Serum and protein free media. In: Al-Rubeai M (ed) Animal cell culture, Cell engineering, vol.9. Springer, Dordrecht, pp 223\u2013236"},{"key":"31_CR13","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1002\/btpr.92","volume":"25","author":"PH van Berkel","year":"2009","unstructured":"van Berkel PH, Gerritsen J, Perdok G, Valbjorn J, Vink T, van de Winkel JG, Parren PW (2009) N-linked glycosylation is an important parameter for optimal selection of cell lines producing biopharmaceutical human IgG. Biotechnol Prog 25:244\u2013251","journal-title":"Biotechnol Prog"},{"issue":"Pt 7","key":"31_CR14","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1099\/0022-1317-66-7-1457","volume":"66","author":"SK Davidson","year":"1985","unstructured":"Davidson SK, Hunt LA (1985) Sindbis virus glycoproteins are abnormally glycosylated in Chinese hamster ovary cells deprived of glucose. J Gen Virol 66(Pt 7):1457\u20131468","journal-title":"J Gen Virol"},{"key":"31_CR15","doi-asserted-by":"publisher","first-page":"6255","DOI":"10.1016\/S0021-9258(19)69156-8","volume":"256","author":"JI Rearick","year":"1981","unstructured":"Rearick JI, Chapman A, Kornfeld S (1981) Glucose starvation alters lipid-linked oligosaccharide biosynthesis in Chinese hamster ovary cells. J Biol Chem 256:6255\u20136261","journal-title":"J Biol Chem"},{"key":"31_CR16","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1042\/bj2720333","volume":"272","author":"EM Curling","year":"1990","unstructured":"Curling EM, Hayter PM, Baines AJ, Bull AT, Gull K, Strange PG, Jenkins N (1990) Recombinant human interferon-gamma. Differences in glycosylation and proteolytic processing lead to heterogeneity in batch culture. Biochem J 272:333\u2013337","journal-title":"Biochem J"},{"key":"31_CR17","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1002\/bit.260390311","volume":"39","author":"PM Hayter","year":"1992","unstructured":"Hayter PM, Curling EM, Baines AJ, Jenkins N, Salmon I, Strange PG, Tong JM, Bull AT (1992) Glucose-limited chemostat culture of Chinese hamster ovary cells producing recombinant human interferon-gamma. Biotechnol Bioeng 39:327\u2013335","journal-title":"Biotechnol Bioeng"},{"key":"31_CR18","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1023\/A:1007980032042","volume":"23","author":"H Tachibana","year":"1997","unstructured":"Tachibana H, Kim JY, Shirahata S (1997) Building high affinity human antibodies by altering the glycosylation on the light chain variable region in N-acetylglucosamine-supplemented hybridoma cultures. Cytotechnology 23:151\u2013159","journal-title":"Cytotechnology"},{"key":"31_CR19","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.jbiotec.2013.11.007","volume":"170","author":"B Liu","year":"2014","unstructured":"Liu B, Spearman M, Doering J, Lattova E, Perreault H, Butler M (2014) The availability of glucose to CHO cells affects the intracellular lipid-linked oligosaccharide distribution, site occupancy and the N-glycosylation profile of a monoclonal antibody. J Biotechnol 170:17\u201327","journal-title":"J Biotechnol"},{"key":"31_CR20","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1002\/biot.201400662","volume":"10","author":"C Villacres","year":"2015","unstructured":"Villacres C, Tayi VS, Lattova E, Perreault H, Butler M (2015) Low glucose depletes glycan precursors, reduces site occupancy and galactosylation of a monoclonal antibody in CHO cell culture. Biotechnol J 10:1051\u20131066","journal-title":"Biotechnol J"},{"key":"31_CR21","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1002\/bit.21816","volume":"100","author":"N Kochanowski","year":"2008","unstructured":"Kochanowski N, Blanchard F, Cacan R, Chirat F, Guedon E, Marc A, Goergen JL (2008) Influence of intracellular nucleotide and nucleotide sugar contents on recombinant interferon-gamma glycosylation during batch and fed-batch cultures of CHO cells. Biotechnol Bioeng 100:721\u2013733","journal-title":"Biotechnol Bioeng"},{"key":"31_CR22","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1002\/(SICI)1097-0290(19990205)62:3<336::AID-BIT10>3.0.CO;2-N","volume":"62","author":"GB Nyberg","year":"1999","unstructured":"Nyberg GB, Balcarcel RR, Follstad BD, Stephanopoulos G, Wang DI (1999) Metabolic effects on recombinant interferon-gamma glycosylation in continuous culture of Chinese hamster ovary cells. Biotechnol Bioeng 62:336\u2013347","journal-title":"Biotechnol Bioeng"},{"key":"31_CR23","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1002\/bit.20317","volume":"89","author":"DCF Wong","year":"2005","unstructured":"Wong DCF, Wong KTK, Goh LT, Heng CK, Yap MGS (2005) Impact of dynamic online fed-batch strategies on metabolism, productivity and N-glycosylation quality in CHO cell cultures. Biotechnol Bioeng 89:164\u2013177","journal-title":"Biotechnol Bioeng"},{"key":"31_CR24","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1021\/bp980005o","volume":"14","author":"SI Grammatikos","year":"1998","unstructured":"Grammatikos SI, Valley U, Nimtz M, Conradt HS, Wagner R (1998) Intracellular UDP-N-acetylhexosamine pool affects N-glycan complexity: a mechanism of ammonium action on protein glycosylation. Biotechnol Prog 14:410\u2013419","journal-title":"Biotechnol Prog"},{"key":"31_CR25","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1002\/bit.260440207","volume":"44","author":"T Ryll","year":"1994","unstructured":"Ryll T, Valley U, Wagner R (1994) Biochemistry of growth inhibition by ammonium ions in mammalian cells. Biotechnol Bioeng 44:184\u2013193","journal-title":"Biotechnol Bioeng"},{"key":"31_CR26","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1021\/bp0101334","volume":"18","author":"M Yang","year":"2002","unstructured":"Yang M, Butler M (2002) Effects of ammonia and glucosamine on the heterogeneity of erythropoietin glycoforms. Biotechnol Prog 18:129\u2013318","journal-title":"Biotechnol Prog"},{"key":"31_CR27","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1002\/(SICI)1097-4652(199811)177:2<248::AID-JCP7>3.0.CO;2-N","volume":"177","author":"JA Zanghi","year":"1998","unstructured":"Zanghi JA, Mendoza TP, Knop RH, Miller WM (1998) Ammonia inhibits neural cell adhesion molecule polysialylation in Chinese hamster ovary and small cell lung cancer cells. J Cell Physiol 177:248\u2013263","journal-title":"J Cell Physiol"},{"key":"31_CR28","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.jbiotec.2011.11.014","volume":"157","author":"M Taschwer","year":"2012","unstructured":"Taschwer M, Hackl M, Hernandez Bort JA, Leitner C, Kumar N, Puc U, Grass J, Papst M, Kunert R, Altmann F, Borth N (2012) Growth, productivity and protein glycosylation in a CHO EpoFc producer cell line adapted to glutamine-free growth. J Biotechnol 157:295\u2013303","journal-title":"J Biotechnol"},{"key":"31_CR29","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1002\/bit.1051","volume":"73","author":"KN Baker","year":"2001","unstructured":"Baker KN, Rendall MH, Hills AE, Hoare M, Freedman RB, James DC (2001) Metabolic control of recombinant protein N-glycan processing in NS0 and CHO cells. Biotechnol Bioeng 73:188\u2013202","journal-title":"Biotechnol Bioeng"},{"key":"31_CR30","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1002\/bit.10022","volume":"75","author":"AE Hills","year":"2001","unstructured":"Hills AE, Patel A, Boyd P, James DC (2001) Metabolic control of recombinant monoclonal antibody N-glycosylation in GS-NS0 cells. Biotechnol Bioeng 75:239\u2013251","journal-title":"Biotechnol Bioeng"},{"key":"31_CR31","doi-asserted-by":"publisher","first-page":"2970","DOI":"10.1002\/bit.24959","volume":"110","author":"RK Grainger","year":"2013","unstructured":"Grainger RK, James DC (2013) CHO cell line specific prediction and control of recombinant monoclonal antibody N-glycosylation. Biotechnol Bioeng 110:2970\u20132983","journal-title":"Biotechnol Bioeng"},{"key":"31_CR32","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1002\/bit.23075","volume":"108","author":"MJ Gramer","year":"2011","unstructured":"Gramer MJ, Eckblad JJ, Donahue R, Brown J, Shultz C, Vickerman K, Priem P, van den Bremer ET, Gerritsen J, van Berkel PH (2011) Modulation of antibody galactosylation through feeding of uridine, manganese chloride, and galactose. Biotechnol Bioeng 108:1591\u20131602","journal-title":"Biotechnol Bioeng"},{"key":"31_CR33","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1002\/bit.22812","volume":"107","author":"NS Wong","year":"2010","unstructured":"Wong NS, Wati L, Nissom PM, Feng HT, Lee MM, Yap MG (2010) An investigation of intracellular glycosylation activities in CHO cells: effects of nucleotide sugar precursor feeding. Biotechnol Bioeng 107:321\u2013336","journal-title":"Biotechnol Bioeng"},{"issue":"Pt 3","key":"31_CR34","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1042\/bj3050865","volume":"305","author":"WR Pels Rijcken","year":"1995","unstructured":"Pels Rijcken WR, Overdijk B, van den Eijnden DH, Ferwerda W (1995) The effect of increasing nucleotide-sugar concentrations on the incorporation of sugars into glycoconjugates in rat hepatocytes. Biochem J 305(Pt 3):865\u2013870","journal-title":"Biochem J"},{"key":"31_CR35","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1002\/(SICI)1097-0290(19980620)58:6<642::AID-BIT10>3.0.CO;2-9","volume":"58","author":"X Gu","year":"1998","unstructured":"Gu X, Wang DI (1998) Improvement of interferon-gamma sialylation in Chinese hamster ovary cell culture by feeding of N-acetylmannosamine. Biotechnol Bioeng 58:642\u2013648","journal-title":"Biotechnol Bioeng"},{"key":"31_CR36","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1002\/bit.25450","volume":"112","author":"Y Fan","year":"2015","unstructured":"Fan Y, del Val Jimenez I, Muller C, Wagtberg Sen J, Rasmussen SK, Kontoravdi C, Weilguny D, Andersen MR (2015) Amino acid and glucose metabolism in fed-batch CHO cell culture affects antibody production and glycosylation. Biotechnol Bioeng 112:521\u2013535","journal-title":"Biotechnol Bioeng"},{"key":"31_CR37","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1093\/glycob\/cwu105","volume":"25","author":"AM Abdel Rahman","year":"2015","unstructured":"Abdel Rahman AM, Ryczko M, Nakano M, Pawling J, Rodrigues T, Johswich A, Taniguchi N, Dennis JW (2015) Golgi N-glycan branching N-acetylglucosaminyltransferases I, V and VI promote nutrient uptake and metabolism. Glycobiology 25:225\u2013240","journal-title":"Glycobiology"},{"key":"31_CR38","volume-title":"Control of glycosylation by environmental manipulations in CHO cell cultures: ll culture effects on the glycosylation","author":"R Kiss","year":"1999","unstructured":"Kiss R, Magreta P, Gray B, Stupp T, Kaneshiro S, Ryll T (1999) Control of glycosylation by environmental manipulations in CHO cell cultures: ll culture effects on the glycosylation. American Chemical Society, Division of Biochemical Technology, Anaheim"},{"key":"31_CR39","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1002\/bit.20439","volume":"90","author":"KJ Clark","year":"2005","unstructured":"Clark KJ, Griffiths J, Bailey KM, Harcum SW (2005) Gene-expression profiles for five key glycosylation genes for galactose-fed CHO cells expressing recombinant IL-4\/13 cytokine trap. Biotechnol Bioeng 90:568\u2013577","journal-title":"Biotechnol Bioeng"},{"key":"31_CR40","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1002\/bit.25715","volume":"113","author":"HF Kildegaard","year":"2016","unstructured":"Kildegaard HF, Fan Y, Sen JW, Larsen B, Andersen MR (2016) Glycoprofiling effects of media additives on IgG produced by CHO cells in fed-batch bioreactors. Biotechnol Bioeng 113:359\u2013366","journal-title":"Biotechnol Bioeng"},{"key":"31_CR41","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1007\/s11274-015-1864-8","volume":"31","author":"J Liu","year":"2015","unstructured":"Liu J, Wang J, Fan L, Chen X, Hu D, Deng X, Poon HF, Wang H, Liu X, Tan WS (2015) Galactose supplementation enhance sialylation of recombinant Fc-fusion protein in CHO cell: an insight into the role of galactosylation in sialylation. World J Microbiol Biotechnol 31:1147\u20131156","journal-title":"World J Microbiol Biotechnol"},{"key":"31_CR42","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1002\/bit.21207","volume":"97","author":"FA Majid","year":"2007","unstructured":"Majid FA, Butler M, Al-Rubeai M (2007) Glycosylation of an immunoglobulin produced from a murine hybridoma cell line: the effect of culture mode and the anti-apoptotic gene, bcl-2. Biotechnol Bioeng 97:156\u2013169","journal-title":"Biotechnol Bioeng"},{"key":"31_CR43","first-page":"44","volume":"1","author":"S Raju","year":"2003","unstructured":"Raju S (2003) Glycosylation variations with expression systems and their impact on bioactivity of therapeutic immunoglobulins. Bioproc Int 1:44\u201353","journal-title":"Bioproc Int"},{"key":"31_CR44","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1002\/bit.21141","volume":"96","author":"CK Crowell","year":"2007","unstructured":"Crowell CK, Grampp GE, Rogers GN, Miller J, Scheinman RI (2007) Amino acid and manganese supplementation modulates the glycosylation state of erythropoietin in a CHO culture system. Biotechnol Bioeng 96:538\u2013549","journal-title":"Biotechnol Bioeng"},{"key":"31_CR45","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1385\/MB:28:3:241","volume":"28","author":"SA Brooks","year":"2004","unstructured":"Brooks SA (2004) Appropriate glycosylation of recombinant proteins for human use: implications of choice of expression system. Mol Biotechnol 28:241\u2013255","journal-title":"Mol Biotechnol"},{"key":"31_CR46","doi-asserted-by":"publisher","first-page":"147","DOI":"10.5661\/bger-28-147","volume":"28","author":"D Ghaderi","year":"2012","unstructured":"Ghaderi D, Zhang M, Hurtado-Ziola N, Varki A (2012) Production platforms for biotherapeutic glycoproteins. Occurrence, impact, and challenges of non-human sialylation. Biotechnol Genet Eng Rev 28:147\u2013175","journal-title":"Biotechnol Genet Eng Rev"},{"key":"31_CR47","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1002\/btpr.2038","volume":"31","author":"N Lin","year":"2015","unstructured":"Lin N, Mascarenhas J, Sealover NR, George HJ, Brooks J, Kayser KJ, Gau B, Yasa I, Azadi P, Archer-Hartmann S (2015) Chinese hamster ovary (CHO) host cell engineering to increase sialylation of recombinant therapeutic proteins by modulating sialyltransferase expression. Biotechnol Prog 31:334\u2013346","journal-title":"Biotechnol Prog"},{"key":"31_CR48","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0157111","volume":"11","author":"AM Lewis","year":"2016","unstructured":"Lewis AM, Croughan WD, Aranibar N, Lee AG, Warrack B, Abu-Absi NR, Patel R, Drew B, Borys MC, Reily MD, Li ZJ (2016) Understanding and controlling sialylation in a CHO Fc-fusion process. PLoS One 11:e0157111","journal-title":"PLoS One"},{"key":"31_CR49","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/S0168-1656(98)00044-3","volume":"62","author":"JP Kunkel","year":"1998","unstructured":"Kunkel JP, Jan DC, Jamieson JC, Butler M (1998) Dissolved oxygen concentration in serum-free continuous culture affects N-linked glycosylation of a monoclonal antibody. J Biotechnol 62:55\u201371","journal-title":"J Biotechnol"},{"key":"31_CR50","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1080\/19420862.2015.1029215","volume":"7","author":"C Raymond","year":"2015","unstructured":"Raymond C, Robotham A, Spearman M, Butler M, Kelly J, Durocher Y (2015) Production of alpha2,6-sialylated IgG1 in CHO cells. MAbs 7:571\u2013583","journal-title":"MAbs"},{"key":"31_CR51","doi-asserted-by":"publisher","first-page":"2343","DOI":"10.1002\/bit.25650","volume":"112","author":"B Yin","year":"2015","unstructured":"Yin B, Gao Y, Chung CY, Yang S, Blake E, Stuczynski MC, Tang J, Kildegaard HF, Andersen MR, Zhang H, Betenbaugh MJ (2015) Glycoengineering of Chinese hamster ovary cells for enhanced erythropoietin N-glycan branching and sialylation. Biotechnol Bioeng 112:2343\u20132351","journal-title":"Biotechnol Bioeng"},{"key":"31_CR52","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.jim.2015.11.009","volume":"428","author":"Y Mimura","year":"2016","unstructured":"Mimura Y, Kelly RM, Unwin L, Albrecht S, Jefferis R, Goodall M, Mizukami Y, Mimura-Kimura Y, Matsumoto T, Ueoka H, Rudd PM (2016) Enhanced sialylation of a human chimeric IgG1 variant produced in human and rodent cell lines. J Immunol Methods 428:30\u201336","journal-title":"J Immunol Methods"},{"key":"31_CR53","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/0168-1656(84)90004-X","volume":"1","author":"M Butler","year":"1984","unstructured":"Butler M, Spier RE (1984) The effects of glutamine utilisation and ammonia production on the growth of BHK cells in microcarrier cultures. J Biotechnol 1:187\u2013196","journal-title":"J Biotechnol"},{"key":"31_CR54","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/0168-1656(90)90053-E","volume":"15","author":"C Doyle","year":"1990","unstructured":"Doyle C, Butler M (1990) The effect of pH on the toxicity of ammonia to a murine hybridoma. J Biotechnol 15:91\u2013100","journal-title":"J Biotechnol"},{"key":"31_CR55","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1016\/0958-1669(94)90072-8","volume":"5","author":"DC Andersen","year":"1994","unstructured":"Andersen DC, Goochee CF (1994) The effect of cell-culture conditions on the oligosaccharide structures of secreted glycoproteins. Curr Opin Biotechnol 5:546\u2013549","journal-title":"Curr Opin Biotechnol"},{"key":"31_CR56","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1002\/(SICI)1097-0290(20000520)68:4<370::AID-BIT2>3.0.CO;2-K","volume":"68","author":"M Yang","year":"2000","unstructured":"Yang M, Butler M (2000) Effects of ammonia on CHO cell growth, erythropoietin production, and glycosylation. Biotechnol Bioeng 68:370\u2013380","journal-title":"Biotechnol Bioeng"},{"key":"31_CR57","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1002\/(SICI)1097-0290(19990820)64:4<401::AID-BIT3>3.0.CO;2-M","volume":"64","author":"U Valley","year":"1999","unstructured":"Valley U, Nimtz M, Conradt HS, Wagner R (1999) Incorporation of ammonium into intracellular UDP-activated N-acetylhexosamines and into carbohydrate structures in glycoproteins. Biotechnol Bioeng 64:401\u2013417","journal-title":"Biotechnol Bioeng"},{"key":"31_CR58","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.jbiotec.2014.07.018","volume":"187","author":"AN Brodsky","year":"2014","unstructured":"Brodsky AN, Caldwell M, Bae S, Harcum SW (2014) Glycosylation-related genes in NS0 cells are insensitive to moderately elevated ammonium concentrations. J Biotechnol 187:78\u201386","journal-title":"J Biotechnol"},{"issue":"Pt 1","key":"31_CR59","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1242\/jcs.104.1.51","volume":"104","author":"RH McDermott","year":"1993","unstructured":"McDermott RH, Butler M (1993) Uptake of glutamate, not glutamine synthetase, regulates adaptation of mammalian cells to glutamine-free medium. J Cell Sci 104(Pt 1):51\u201358","journal-title":"J Cell Sci"},{"key":"31_CR60","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.jbiotec.2014.04.002","volume":"180","author":"TK Ha","year":"2014","unstructured":"Ha TK, Lee GM (2014) Effect of glutamine substitution by TCA cycle intermediates on the production and sialylation of Fc-fusion protein in Chinese hamster ovary cell culture. J Biotechnol 180:23\u201329","journal-title":"J Biotechnol"},{"key":"31_CR61","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.jbiotec.2014.05.024","volume":"186","author":"H Aghamohseni","year":"2014","unstructured":"Aghamohseni H, Ohadi K, Spearman M, KRAHN N, Moo-Young M, Scharer JM, Butler M, Budman HM (2014) Effects of nutrient levels and average culture pH on the glycosylation pattern of camelid-humanized monoclonal antibody. J Biotechnol 186:98\u2013109","journal-title":"J Biotechnol"},{"key":"31_CR62","first-page":"720","volume":"11","author":"MC Borys","year":"1993","unstructured":"Borys MC, Linzer DI, Papoutsakis ET (1993) Culture pH affects expression rates and glycosylation of recombinant mouse placental lactogen proteins by Chinese hamster ovary (CHO) cells. Biotechnology 11:720\u2013724","journal-title":"Biotechnology"},{"key":"31_CR63","doi-asserted-by":"publisher","first-page":"5283","DOI":"10.1007\/s00253-013-4849-2","volume":"97","author":"JS Seo","year":"2013","unstructured":"Seo JS, Kim YJ, Cho JM, Baek E, Lee GM (2013) Effect of culture pH on recombinant antibody production by a new human cell line, F2N78, grown in suspension at 33.0\u00b0 C and 37.0\u00b0 C. Appl Microbiol Biotechnol 97:5283\u20135291","journal-title":"Appl Microbiol Biotechnol"},{"key":"31_CR64","doi-asserted-by":"publisher","first-page":"7011","DOI":"10.1007\/s00253-016-7380-4","volume":"100","author":"D Zalai","year":"2016","unstructured":"Zalai D, Hever H, Lovasz K, Molnar D, Wechselberger P, Hofer A, Parta L, Putics A, Herwig C (2016) A control strategy to investigate the relationship between specific productivity and high-mannose glycoforms in CHO cells. Appl Microbiol Biotechnol 100:7011\u20137024","journal-title":"Appl Microbiol Biotechnol"},{"key":"31_CR65","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1002\/bit.25524","volume":"112","author":"SN Sou","year":"2015","unstructured":"Sou SN, Sellick C, Lee K, Mason A, Kyriakopoulos S, Polizzi KM, Kontoravdi C (2015) How does mild hypothermia affect monoclonal antibody glycosylation? Biotechnol Bioeng 112:1165\u20131176","journal-title":"Biotechnol Bioeng"},{"key":"31_CR66","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1023\/A:1007917409455","volume":"26","author":"R Heidemann","year":"1998","unstructured":"Heidemann R, Lutkemeyer D, Buntemeyer H, Lehmann J (1998) Effects of dissolved oxygen levels and the role of extra- and intracellular amino acid concentrations upon the metabolism of mammalian cell lines during batch and continuous cultures. Cytotechnology 26:185\u2013197","journal-title":"Cytotechnology"},{"key":"31_CR67","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1002\/(SICI)1097-0290(19970420)54:2<153::AID-BIT7>3.0.CO;2-K","volume":"54","author":"DC Jan","year":"1997","unstructured":"Jan DC, Petch DA, Huzel N, Butler M (1997) The effect of dissolved oxygen on the metabolic profile of a murine hybridoma grown in serum-free medium in continuous culture. Biotechnol Bioeng 54:153\u2013164","journal-title":"Biotechnol Bioeng"},{"key":"31_CR68","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1007\/BF00762396","volume":"15","author":"W Chotigeat","year":"1994","unstructured":"Chotigeat W, Watanapokasin Y, Mahler S, Gray PP (1994) Role of environmental conditions on the expression levels, glycoform pattern and levels of sialyltransferase for hFSH produced by recombinant CHO cells. Cytotechnology 15:217\u2013221","journal-title":"Cytotechnology"},{"key":"31_CR69","first-page":"875","volume":"13","author":"JP Kunkel","year":"2003","unstructured":"Kunkel JP, Yan WY, Butler M, Jamieson JC (2003) Decreased monoclonal IgG1 galactosylation at reduced dissolved oxygen concentration is not a result of lowered galactosyltransferase activity in vitro. Glycobiology 13:875","journal-title":"Glycobiology"},{"key":"31_CR70","doi-asserted-by":"publisher","first-page":"15599","DOI":"10.1016\/S0021-9258(18)55439-9","volume":"265","author":"AD Elbein","year":"1990","unstructured":"Elbein AD, Tropea JE, Mitchell M, Kaushal GP (1990) Kifunensine, a potent inhibitor of the glycoprotein processing mannosidase I. J Biol Chem 265:15599\u201315605","journal-title":"J Biol Chem"},{"key":"31_CR71","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1006\/abbi.1996.0014","volume":"325","author":"S Weng","year":"1996","unstructured":"Weng S, Spiro RG (1996) Endoplasmic reticulum kifunensine-resistant alpha-mannosidase is enzymatically and immunologically related to the cytosolic alpha-mannosidase. Arch Biochem Biophys 325:113\u2013123","journal-title":"Arch Biochem Biophys"},{"key":"31_CR72","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1002\/bit.21598","volume":"99","author":"Q Zhou","year":"2008","unstructured":"Zhou Q, Shankara S, Roy A, Qiu H, Estes S, Mcvie-Wylie A, Culm-Merdek K, Park A, Pan C, Edmunds T (2008) Development of a simple and rapid method for producing non-fucosylated oligomannose containing antibodies with increased effector function. Biotechnol Bioeng 99:652\u2013665","journal-title":"Biotechnol Bioeng"},{"key":"31_CR73","doi-asserted-by":"publisher","first-page":"4179","DOI":"10.1074\/jbc.272.7.4179","volume":"272","author":"JE van Leeuwen","year":"1997","unstructured":"van Leeuwen JE, Kearse KP (1997) Reglucosylation of N-linked glycans is critical for calnexin assembly with T cell receptor (TCR) alpha proteins but not TCRbeta proteins. J Biol Chem 272:4179\u20134186","journal-title":"J Biol Chem"},{"key":"31_CR74","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1093\/glycob\/cwj119","volume":"16","author":"M Crispin","year":"2006","unstructured":"Crispin M, Harvey DJ, Chang VT, Yu C, Aricescu AR, Jones EY, Davis SJ, Dwek RA, Rudd PM (2006) Inhibition of hybrid- and complex-type glycosylation reveals the presence of the GlcNAc transferase I-independent fucosylation pathway. Glycobiology 16:748\u2013756","journal-title":"Glycobiology"},{"key":"31_CR75","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/j.ejps.2016.09.040","volume":"96","author":"N Krahn","year":"2017","unstructured":"Krahn N, Spearman M, Meier M, Dorion-Thibaudeau J, McDougall M, Patel TR, de Crescenzo G, Durocher Y, Stetefeld J, Butler M (2017) Inhibition of glycosylation on a camelid antibody uniquely affects its FcgammaRI binding activity. Eur J Pharm Sci 96:428\u2013439","journal-title":"Eur J Pharm Sci"},{"key":"31_CR76","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1016\/j.drudis.2010.06.009","volume":"15","author":"G Walsh","year":"2010","unstructured":"Walsh G (2010) Post-translational modifications of protein biopharmaceuticals. Drug Discov Today 15:773\u2013780","journal-title":"Drug Discov Today"},{"key":"31_CR77","first-page":"71","volume":"127","author":"ZP Gerdtzen","year":"2012","unstructured":"Gerdtzen ZP (2012) Modeling metabolic networks for mammalian cell systems: general considerations, modeling strategies, and available tools. Adv Biochem Eng Biotechnol 127:71\u2013108","journal-title":"Adv Biochem Eng Biotechnol"},{"key":"31_CR78","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1002\/biot.201400664","volume":"10","author":"CA Sellick","year":"2015","unstructured":"Sellick CA, Croxford AS, Maqsood AR, Stephens GM, Westerhoff HV, Goodacre R, Dickson AJ (2015) Metabolite profiling of CHO cells: molecular reflections of bioprocessing effectiveness. Biotechnol J 10:1434\u20131445","journal-title":"Biotechnol J"},{"key":"31_CR79","doi-asserted-by":"publisher","first-page":"a005199","DOI":"10.1101\/cshperspect.a005199","volume":"3","author":"P Stanley","year":"2011","unstructured":"Stanley P (2011) Golgi glycosylation. Cold Spring Harb Perspect Biol 3:a005199","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"31_CR80","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0000713","volume":"2","author":"P Hossler","year":"2007","unstructured":"Hossler P, Mulukutla BC, Hu WS (2007) Systems analysis of N-glycan processing in mammalian cells. PLoS One 2:e713","journal-title":"PLoS One"},{"key":"31_CR81","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.ymben.2015.10.007","volume":"33","author":"PN Spahn","year":"2016","unstructured":"Spahn PN, Hansen AH, Hansen HG, Arnsdorf J, Kildegaard HF, Lewis NE (2016) A Markov chain model for N-linked protein glycosylation--towards a low-parameter tool for model-driven glycoengineering. Metab Eng 33:52\u201366","journal-title":"Metab Eng"},{"key":"31_CR82","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1002\/bit.21062","volume":"95","author":"P Hossler","year":"2006","unstructured":"Hossler P, Goh LT, Lee MM, Hu WS (2006) GlycoVis: visualizing glycan distribution in the protein N-glycosylation pathway in mammalian cells. Biotechnol Bioeng 95:946\u2013960","journal-title":"Biotechnol Bioeng"},{"key":"31_CR83","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1186\/1472-6750-11-95","volume":"11","author":"SC Burleigh","year":"2011","unstructured":"Burleigh SC, van de Laar T, Stroop CJ, van Grunsven WM, O'Donoghue N, Rudd PM, Davey GP (2011) Synergizing metabolic flux analysis and nucleotide sugar metabolism to understand the control of glycosylation of recombinant protein in CHO cells. BMC Biotechnol 11:95","journal-title":"BMC Biotechnol"},{"key":"31_CR84","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1002\/(SICI)1097-0290(19970920)55:6<890::AID-BIT7>3.0.CO;2-B","volume":"55","author":"P Umana","year":"1997","unstructured":"Umana P, Bailey JE (1997) A mathematical model of N-linked glycoform biosynthesis. Biotechnol Bioeng 55:890\u2013908","journal-title":"Biotechnol Bioeng"},{"key":"31_CR85","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1093\/glycob\/cwp081","volume":"19","author":"FJ Krambeck","year":"2009","unstructured":"Krambeck FJ, Bennun SV, Narang S, Choi S, Yarema KJ, Betenbaugh MJ (2009) A mathematical model to derive N-glycan structures and cellular enzyme activities from mass spectrometric data. Glycobiology 19:1163\u20131175","journal-title":"Glycobiology"},{"key":"31_CR86","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1002\/bit.20645","volume":"92","author":"FJ Krambeck","year":"2005","unstructured":"Krambeck FJ, Betenbaugh MJ (2005) A mathematical model of N-linked glycosylation. Biotechnol Bioeng 92:711\u2013728","journal-title":"Biotechnol Bioeng"},{"key":"31_CR87","first-page":"5014","volume":"127","author":"AG McDonald","year":"2014","unstructured":"McDonald AG, Hayes JM, Bezak T, Gluchowska SA, Cosgrave EF, Struwe WB, Stroop CJ, Kok H, van de Laar T, Rudd PM, Tipton KF, Davey GP (2014) Galactosyltransferase 4 is a major control point for glycan branching in N-linked glycosylation. J Cell Sci 127:5014\u20135026","journal-title":"J Cell Sci"},{"key":"31_CR88","doi-asserted-by":"crossref","unstructured":"Ohadi K, Aghamohseni H, G\u00e4dke J, Moo-Young M, Legge R, Scharer J, Budman H (2013) Novel dynamic model to predict the glycosylation pattern of monoclonal antibodies from extracellular cell culture conditions. 12th IFAC symposium on computer applications in biotechnology. IFAC Proc Vol 46(31): 30\u201335","DOI":"10.3182\/20131216-3-IN-2044.00009"},{"key":"31_CR89","doi-asserted-by":"publisher","first-page":"4492","DOI":"10.3390\/ijms15034492","volume":"15","author":"PM Jedrzejewski","year":"2014","unstructured":"Jedrzejewski PM, del Val IJ, Constantinou A, Dell A, Haslam SM, Polizzi KM, Kontoravdi C (2014) Towards controlling the glycoform: a model framework linking extracellular metabolites to antibody glycosylation. Int J Mol Sci 15:4492\u20134522","journal-title":"Int J Mol Sci"},{"key":"31_CR90","doi-asserted-by":"publisher","first-page":"28547","DOI":"10.1038\/srep28547","volume":"6","author":"IJ del Val","year":"2016","unstructured":"del Val IJ, Polizzi KM, Kontoravdi C (2016) A theoretical estimate for nucleotide sugar demand towards Chinese Hamster ovary cellular glycosylation. Sci Rep 6:28547","journal-title":"Sci Rep"},{"key":"31_CR91","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1002\/btpr.2155","volume":"31","author":"AS Rathore","year":"2015","unstructured":"Rathore AS, Kumar Singh S, Pathak M, Read EK, Brorson KA, Agarabi CD, Khan M (2015) Fermentanomics: relating quality attributes of a monoclonal antibody to cell culture process variables and raw materials using multivariate data analysis. Biotechnol Prog 31:1586\u20131599","journal-title":"Biotechnol Prog"},{"key":"31_CR92","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.coviro.2016.03.002","volume":"17","author":"A Cho","year":"2016","unstructured":"Cho A, Wrammert J (2016) Implications of broadly neutralizing antibodies in the development of a universal influenza vaccine. Curr Opin Virol 17:110\u2013115","journal-title":"Curr Opin Virol"},{"key":"31_CR93","first-page":"165","volume":"3","author":"J Steel","year":"2015","unstructured":"Steel J (2015) A paradigm shift in vaccine production for pandemic influenza. Ann Transl Med 3:165","journal-title":"Ann Transl Med"},{"key":"31_CR94","doi-asserted-by":"publisher","first-page":"886","DOI":"10.3349\/ymj.2012.53.5.886","volume":"53","author":"JI Kim","year":"2012","unstructured":"Kim JI, Park MS (2012) N-linked glycosylation in the hemagglutinin of influenza A viruses. Yonsei Med J 53:886\u2013893","journal-title":"Yonsei Med J"},{"key":"31_CR95","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1586\/erv.09.128","volume":"8","author":"Y Genzel","year":"2009","unstructured":"Genzel Y, Reichl U (2009) Continuous cell lines as a production system for influenza vaccines. Expert Rev Vaccines 8:1681\u20131692","journal-title":"Expert Rev Vaccines"},{"key":"31_CR96","volume-title":"Animal cell biotechnology: methods and protocols","author":"Y Genzel","year":"2014","unstructured":"Genzel Y, Rodig J, Rapp E, Reichl U (2014) Vaccine production: upstream processing with adherent or suspension cell lines. In: Portner R (ed) Animal cell biotechnology: methods and protocols3rd edn. Humana, Totowa","edition":"3"},{"key":"31_CR97","doi-asserted-by":"publisher","first-page":"1672","DOI":"10.3390\/v6041672","volume":"6","author":"I Jordan","year":"2014","unstructured":"Jordan I, Sandig V (2014) Matrix and backstage: cellular substrates for viral vaccines. Virus 6:1672\u20131700","journal-title":"Virus"},{"key":"31_CR98","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1002\/biot.201400387","volume":"10","author":"AF Rodrigues","year":"2015","unstructured":"Rodrigues AF, Soares HR, Guerreiro MR, Alves PM, Coroadinha AS (2015) Viral vaccines and their manufacturing cell substrates: new trends and designs in modern vaccinology. Biotechnol J 10:1329\u20131344","journal-title":"Biotechnol J"},{"key":"31_CR99","doi-asserted-by":"publisher","first-page":"549","DOI":"10.2217\/fvl-2016-0006","volume":"11","author":"MA Zahoor","year":"2016","unstructured":"Zahoor MA, Khurshid M, Qureshi R, Naz A, Shahid M (2016) Cell culture-based viral vaccines: current status and future prospects. Futur Virol 11:549\u2013562","journal-title":"Futur Virol"},{"key":"31_CR100","doi-asserted-by":"publisher","first-page":"2716","DOI":"10.1016\/S0264-410X(00)00508-9","volume":"19","author":"MG Pau","year":"2001","unstructured":"Pau MG, Ophorst C, Koldijk MH, Schouten G, Mehtali M, Uytdehaag F (2001) The human cell line PER.C6 provides a new manufacturing system for the production of influenza vaccines. Vaccine 19:2716\u20132721","journal-title":"Vaccine"},{"key":"31_CR101","doi-asserted-by":"publisher","first-page":"6611","DOI":"10.1016\/j.vaccine.2015.10.091","volume":"33","author":"BP Sanders","year":"2015","unstructured":"Sanders BP, Oakes Ide L, van Hoek V, Liu Y, Marissen W, Minor PD, Wimmer E, Schuitemaker H, Custers JH, Macadam A, Cello J, Edo-Matas D (2015) Production of high titer attenuated poliovirus strains on the serum-free PER.C6((R)) cell culture platform for the generation of safe and affordable next generation IPV. Vaccine 33:6611\u20136616","journal-title":"Vaccine"},{"key":"31_CR102","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1016\/j.vaccine.2008.11.066","volume":"27","author":"I Jordan","year":"2009","unstructured":"Jordan I, Vos A, Beilfuss S, Neubert A, Breul S, Sandig V (2009) An avian cell line designed for production of highly attenuated viruses. Vaccine 27:748\u2013756","journal-title":"Vaccine"},{"key":"31_CR103","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1002\/biot.201400388","volume":"10","author":"Y Genzel","year":"2015","unstructured":"Genzel Y (2015) Designing cell lines for viral vaccine production: where do we stand? Biotechnol J 10:728\u2013740","journal-title":"Biotechnol J"},{"key":"31_CR104","unstructured":"Guehenneux F, Moreau K, Esnault M, Mehtali M (2008) Duck embryonic derived stem cell lines for the production of viral vaccines. Patent WO\/2008\/129058 A1"},{"key":"31_CR105","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1093\/infdis\/jiv091","volume":"212","author":"A Schuind","year":"2015","unstructured":"Schuind A, Segall N, Drame M, Innis BL (2015) Immunogenicity and safety of an EB66 cell-culture-derived influenza A\/Indonesia\/5\/2005(H5N1) AS03-adjuvanted vaccine: a phase 1 randomized trial. J Infect Dis 212:531\u2013541","journal-title":"J Infect Dis"},{"key":"31_CR106","doi-asserted-by":"publisher","first-page":"91","DOI":"10.4149\/av_2013_02_91","volume":"57","author":"T Betakova","year":"2013","unstructured":"Betakova T, Svetlikova D, Gocnik M (2013) Overview of measles and mumps vaccine: origin, present, and future of vaccine production. Acta Virol 57:91\u201396","journal-title":"Acta Virol"},{"key":"31_CR107","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1038\/227168a0","volume":"227","author":"JP Jacobs","year":"1970","unstructured":"Jacobs JP, Jones CM, Baille JP (1970) Characteristics of a human diploid cell designated MRC-5. Nature 227:168\u2013170","journal-title":"Nature"},{"key":"31_CR108","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1586\/erv.09.19","volume":"8","author":"PN Barrett","year":"2009","unstructured":"Barrett PN, Mundt W, Kistner O, Howard MK (2009) Vero cell platform in vaccine production: moving towards cell culture-based viral vaccines. Expert Rev Vaccines 8:607\u2013618","journal-title":"Expert Rev Vaccines"},{"key":"31_CR109","first-page":"431","volume":"73","author":"N Cox","year":"1995","unstructured":"Cox N, Hannoun C, Hay A, Kaverin NV, Kilbourne ED, Webster R, Levandowski RA, Schild G, Wood J, Ghendon Y, Grachev V, Griffiths E, Martinez LJ (1995) Cell-culture as a substrate for the production of influenza vaccines \u2013 memorandum from a WHO meeting. Bull World Health Organ 73:431\u2013435","journal-title":"Bull World Health Organ"},{"key":"31_CR110","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1586\/erv.09.31","volume":"8","author":"A Doroshenko","year":"2009","unstructured":"Doroshenko A, Halperin SA (2009) Trivalent MDCK cell culture-derived influenza vaccine Optaflu (Novartis vaccines). Expert Rev Vaccines 8:679\u2013688","journal-title":"Expert Rev Vaccines"},{"key":"31_CR111","unstructured":"WHO (2005) Recommendations for the production and control of influenza vaccine (inactivated). WHO Technical Report Series, No. 927, Annex 3. World Health Organization, Geneva. http:\/\/www.who.int\/biologicals\/publications\/trs\/areas\/vaccines\/influenza\/ANNEX%203%20InfluenzaP99-134.pdf?ua=1. http:\/\/www.who.int\/biologicals\/publications\/trs\/areas\/vaccines\/influenza\/en\/"},{"key":"31_CR112","unstructured":"EMEA (2008) Guideline on development, production, characterisation and specifications for monoclonal antibodies and related products. Committee For Medicinal Products For Human Use (CHMP), European Medicines Agency, London. http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/Scientific_guideline\/2009\/09\/WC500003074.pdf. http:\/\/www.ema.europa.eu\/ema\/index.jsp?curl=pages\/regulation\/general\/general_content_000867.jsp&mid=WC0b01ac058002956b"},{"key":"31_CR113","unstructured":"WHO (2011) Guidelines on regulatory preparedness for human pandemic influenza vaccines WHO Technical Report Series, No. 963. Annex 2. World Health Organization, Geneva. http:\/\/www.who.int\/biologicals\/vaccines\/Annex_2_WHO_TRS_963-3.pdf"},{"key":"31_CR114","first-page":"760","volume":"137","author":"J Hutter","year":"2012","unstructured":"Hutter J, Rodig J, Hoper D, Reichl U, Seeberger PH, Rapp E, Lepenies B (2012) Glycosylation matters: role of viral hemagglutinin N-glycosylation in immunogenicity. Immunology 137:760\u2013761","journal-title":"Immunology"},{"key":"31_CR115","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.jchromb.2016.04.025","volume":"2016","author":"C Lancaster","year":"2016","unstructured":"Lancaster C, Pristatsky P, Hoang VM, Casimiro DR, Schwartz RM, Rustandi R, Ha S (2016) Characterization of N-glycosylation profiles from mammalian and insect cell derived chikungunya VLP. J Chromatogr B Analyt Technol Biomed Life Sci 2016:218\u2013223","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"31_CR116","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0066719","volume":"8","author":"SC Lin","year":"2013","unstructured":"Lin SC, Jan JT, Dionne B, Butler M, Huang MH, Wu CY, Wong CH, Wu SC (2013) Different immunity elicited by recombinant H5N1 hemagglutinin proteins containing pauci-mannose, high-mannose, or complex type N-glycans. PLoS One 8:e66719","journal-title":"PLoS One"},{"key":"31_CR117","doi-asserted-by":"publisher","first-page":"6085","DOI":"10.1128\/JVI.00452-16","volume":"90","author":"WC Liu","year":"2016","unstructured":"Liu WC, Lin YL, Spearman M, Cheng PY, Butler M, Wu SC (2016) Influenza virus hemagglutinin glycoproteins with different N-glycan patterns activate dendritic cells in vitro. J Virol 90:6085\u20136096","journal-title":"J Virol"},{"key":"31_CR118","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1038\/nchembio.1403","volume":"9","author":"MA Wolfert","year":"2013","unstructured":"Wolfert MA, Boons GJ (2013) Adaptive immune activation: glycosylation does matter. Nat Chem Biol 9:776\u2013784","journal-title":"Nat Chem Biol"},{"key":"31_CR119","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1038\/nature01470","volume":"422","author":"XP Wei","year":"2003","unstructured":"Wei XP, Decker JM, Wang SY, Hui HX, Kappes JC, Wu XY, Salazar-Gonzalez JF, Salazar MG, Kilby JM, Saag MS, Komarova NL, Nowak MA, Hahn BH, Kwong PD, Shaw GM (2003) Antibody neutralization and escape by HIV-1. Nature 422:307\u2013312. (Erratum, Nature 423: 197)","journal-title":"Nature"},{"key":"31_CR120","doi-asserted-by":"publisher","first-page":"9605","DOI":"10.1128\/JVI.78.18.9605-9611.2004","volume":"78","author":"Y Abe","year":"2004","unstructured":"Abe Y, Takashita E, Sugawara K, Matsuzaki Y, Muraki Y, Hongo S (2004) Effect of the addition of oligosaccharides on the biological activities and antigenicity of influenza A\/H3N2 virus hemagglutinin. J Virol 78:9605\u20139611","journal-title":"J Virol"},{"key":"31_CR121","doi-asserted-by":"publisher","first-page":"3707","DOI":"10.1021\/pr400329k","volume":"12","author":"Y An","year":"2013","unstructured":"An Y, Rininger JA, Jarvis DL, Jing X, Ye Z, Aumiller JJ, Eichelberger M, Cipollo JF (2013) Comparative glycomics analysis of influenza Hemagglutinin (H5N1) produced in vaccine relevant cell platforms. J Proteome Res 12:3707\u20133720","journal-title":"J Proteome Res"},{"key":"31_CR122","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.3390\/v3101909","volume":"3","author":"F Helle","year":"2011","unstructured":"Helle F, Duverlie G, Dubuisson J (2011) The hepatitis C virus glycan shield and evasion of the humoral immune response. Viruses 3:1909\u20131932","journal-title":"Viruses"},{"key":"31_CR123","doi-asserted-by":"publisher","first-page":"1764","DOI":"10.1016\/j.bbagen.2015.08.007","volume":"1860","author":"Y Ren","year":"2016","unstructured":"Ren Y, Min Y-Q, Liu M, Chi L, Zhao P, Zhang X-L (2016) N-glycosylation-mutated HCV envelope glycoprotein complex enhances antigen-presenting activity and cellular and neutralizing antibody responses. Biochim Biophys Acta-Gen Subj 1860:1764\u20131775","journal-title":"Biochim Biophys Acta-Gen Subj"},{"key":"31_CR124","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.3390\/v6031294","volume":"6","author":"MD Tate","year":"2014","unstructured":"Tate MD, Job ER, Deng YM, Gunalan V, Maurer-Stroh S, Reading PC (2014) Playing hide and seek: how glycosylation of the influenza virus hemagglutinin can modulate the immune response to infection. Virus 6:1294\u20131316","journal-title":"Virus"},{"key":"31_CR125","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/S0042-6822(03)00008-4","volume":"308","author":"RA Bright","year":"2003","unstructured":"Bright RA, Ross TM, Subbarao K, Robinson HL, Katz JM (2003) Impact of glycosylation on the immunogenicity of a DNA-based influenza H5 HA vaccine. Virology 308:270\u2013278","journal-title":"Virology"},{"issue":"Suppl","key":"31_CR126","doi-asserted-by":"publisher","first-page":"S115","DOI":"10.1016\/j.jinf.2016.04.031","volume":"72","author":"R Cao","year":"2016","unstructured":"Cao R, Mejias A, Ramilo O (2016) Systems immunology: beyond antibody titers. J Infect 72(Suppl):S115\u2013S118","journal-title":"J Infect"},{"key":"31_CR127","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1038\/nm.3743","volume":"21","author":"BJ Dekosky","year":"2015","unstructured":"Dekosky BJ, Kojima T, Rodin A, Charab W, Ippolito GC, Ellington AD, Georgiou G (2015) In-depth determination and analysis of the human paired heavy- and light-chain antibody repertoire. Nat Med 21:86\u201391","journal-title":"Nat Med"},{"key":"31_CR128","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/978-1-4939-2874-3_8","volume":"1331","author":"R Hennig","year":"2015","unstructured":"Hennig R, Rapp E, Kottler R, Cajic S, Borowiak M, Reichl U (2015) N-Glycosylation fingerprinting of viral glycoproteins by xCGE-LIF. Methods Mol Biol 1331:123\u2013143","journal-title":"Methods Mol Biol"},{"key":"31_CR129","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1074\/mcp.M113.037465","volume":"13","author":"JE Huffman","year":"2014","unstructured":"Huffman JE, Pucic-Bakovic M, Klaric L, Hennig R, Selman MHJ, Vuckovic F, Novokmet M, Kristic J, Borowiak M, Muth T, Polasek O, Razdorov G, Gornik O, Plomp R, Theodoratou E, Wright AF, Rudan I, Hayward C, Campbell H, Deelder AM, Reichl U, Aulchenko YS, Rapp E, Wuhrer M, Lauc G (2014) Comparative Performance of four methods for high-throughput glycosylation analysis of immunoglobulin G in genetic and epidemiological research. Mol Cell Proteomics 13:1598\u20131610","journal-title":"Mol Cell Proteomics"},{"key":"31_CR130","doi-asserted-by":"publisher","first-page":"2311","DOI":"10.1002\/elps.201200696","volume":"34","author":"A Behne","year":"2013","unstructured":"Behne A, Muth T, Borowiak M, Reichl U, Rapp E (2013) glyXalign: high-throughput migration time alignment preprocessing of electrophoretic data retrieved via multiplexed capillary gel electrophoresis with laser-induced fluorescence detection-based glycoprofiling. Electrophoresis 34:2311\u20132315","journal-title":"Electrophoresis"},{"key":"31_CR131","doi-asserted-by":"publisher","first-page":"4203","DOI":"10.1002\/elps.200800042","volume":"29","author":"J Schwarzer","year":"2008","unstructured":"Schwarzer J, Rapp E, Reichl U (2008) N-glycan analysis by CGE-LIF: profiling influenza A virus hemagglutinin N-glycosylation during vaccine production. Electrophoresis 29:4203\u20134214","journal-title":"Electrophoresis"},{"key":"31_CR132","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1038\/nprot.2016.024","volume":"11","author":"JR McDaniel","year":"2016","unstructured":"McDaniel JR, Dekosky BJ, Tanno H, Ellington AD, Georgiou G (2016) Ultra-high-throughput sequencing of the immune receptor repertoire from millions of lymphocytes. Nat Protoc 11:429\u2013442","journal-title":"Nat Protoc"},{"key":"31_CR133","doi-asserted-by":"publisher","first-page":"2217","DOI":"10.1074\/mcp.O116.058503","volume":"15","author":"R Plomp","year":"2016","unstructured":"Plomp R, Bondt A, de Haan N, Rombouts Y, Wuhrer M (2016) Recent advances in clinical glycoproteomics of immunoglobulins (Igs). Mol Cell Proteomics 15:2217\u20132228","journal-title":"Mol Cell Proteomics"},{"key":"31_CR134","doi-asserted-by":"publisher","first-page":"8756","DOI":"10.1128\/JVI.00593-13","volume":"87","author":"X Sun","year":"2013","unstructured":"Sun X, Jayaraman A, Maniprasad P, Raman R, Houser KV, Pappas C, Zeng H, Sasisekharan R, Katz JM, Tumpey TM (2013) N-linked glycosylation of the hemagglutinin protein influences virulence and antigenicity of the 1918 pandemic and seasonal H1N1 influenza A viruses. J Virol 87:8756\u20138766","journal-title":"J Virol"},{"key":"31_CR135","doi-asserted-by":"publisher","first-page":"2926","DOI":"10.1016\/j.vaccine.2016.03.085","volume":"34","author":"F Berlanda Scorza","year":"2016","unstructured":"Berlanda Scorza F, Tsvetnitsky V, Donnelly JJ (2016) Universal influenza vaccines: Shifting to better vaccines. Vaccine 34:2926\u20132933","journal-title":"Vaccine"},{"key":"31_CR136","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1128\/JVI.02608-13","volume":"88","author":"D Eggink","year":"2014","unstructured":"Eggink D, Goff PH, Palese P (2014) Guiding the immune response against influenza virus hemagglutinin toward the conserved stalk domain by hyperglycosylation of the globular head domain. J Virol 88:699\u2013704","journal-title":"J Virol"},{"key":"31_CR137","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.coviro.2016.02.002","volume":"17","author":"F Krammer","year":"2016","unstructured":"Krammer F (2016) Novel universal influenza virus vaccine approaches. Curr Opin Virol 17:95\u2013103","journal-title":"Curr Opin Virol"},{"key":"31_CR138","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1111\/irv.12383","volume":"10","author":"JP Weir","year":"2016","unstructured":"Weir JP, Gruber MF (2016) An overview of the regulation of influenza vaccines in the United States. Influenza Other Respir Viruses 10:354\u2013360","journal-title":"Influenza Other Respir Viruses"},{"key":"31_CR139","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1155\/2015\/504831","volume":"2015","author":"E Milian","year":"2015","unstructured":"Milian E, Kamen AA (2015) Current and emerging cell culture manufacturing technologies for influenza vaccines. Biomed Res Int 2015:11","journal-title":"Biomed Res Int"},{"key":"31_CR140","doi-asserted-by":"publisher","first-page":"375","DOI":"10.3947\/ic.2013.45.4.375","volume":"45","author":"JY Noh","year":"2013","unstructured":"Noh JY, Kim WJ (2013) Influenza vaccines: unmet needs and recent developments. Infect Chemother 45:375\u2013386","journal-title":"Infect Chemother"},{"key":"31_CR141","first-page":"93","volume":"98","author":"R Brands","year":"1999","unstructured":"Brands R, Visser J, Medema J, Palache AM, van Scharrenburg GJ (1999) Influvac: a safe Madin Darby canine kidney (MDCK) cell culture-based influenza vaccine. Dev Biol Stand 98:93\u2013111","journal-title":"Dev Biol Stand"},{"key":"31_CR142","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1586\/14760584.2015.1039520","volume":"14","author":"I Manini","year":"2015","unstructured":"Manini I, Domnich A, Amicizia D, Rossi S, Pozzi T, Gasparini R, Panatto D, Montomoli E (2015) Flucelvax (Optaflu) for seasonal influenza. Expert Rev Vaccines 14:789\u2013804","journal-title":"Expert Rev Vaccines"},{"key":"31_CR143","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.biologicals.2009.02.014","volume":"37","author":"MMJ Cox","year":"2009","unstructured":"Cox MMJ, Hollister JR (2009) FluBlok, a next generation influenza vaccine manufactured in insect cells. Biologicals 37:182\u2013189","journal-title":"Biologicals"},{"key":"31_CR144","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/S0042-6822(03)00377-5","volume":"313","author":"L Mochalova","year":"2003","unstructured":"Mochalova L, Gambaryan A, Romanova J, Tuzikov A, Chinarev A, Katinger D, Katinger H, Egorov A, Bovin N (2003) Receptor-binding properties of modern human influenza viruses primarily isolated in Vero and MDCK cells and chicken embryonated eggs. Virology 313:473\u2013480","journal-title":"Virology"},{"key":"31_CR145","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/S0042-6822(02)00064-8","volume":"307","author":"J Romanova","year":"2003","unstructured":"Romanova J, Katinger D, Ferko B, Voglauer R, Mochalova L, Bovin N, Lim W, Katinger H, Egorov A (2003) Distinct host range of influenza h3n2 virus isolates in vero and mdck cells is determined by cell specific glycosylation pattern. Virology 307:90\u201397","journal-title":"Virology"},{"key":"31_CR146","doi-asserted-by":"publisher","first-page":"4325","DOI":"10.1016\/j.vaccine.2009.04.076","volume":"27","author":"J Schwarzer","year":"2009","unstructured":"Schwarzer J, Rapp E, Hennig R, Genzel Y, Jordan I, Sandig V, Reichl U (2009) Glycan analysis in cell culture-based influenza vaccine production: influence of host cell line and virus strain on the glycosylation pattern of viral hemagglutinin. Vaccine 27:4325\u20134336","journal-title":"Vaccine"},{"key":"31_CR147","doi-asserted-by":"publisher","first-page":"8868","DOI":"10.1021\/bi010475i","volume":"40","author":"TS Raju","year":"2001","unstructured":"Raju TS, Briggs JB, Chamow SM, Winkler ME, Jones AJS (2001) Glycoengineering of therapeutic glycoproteins: in vitro galactosylation and sialylation of glycoproteins with terminal N-acetylglucosamine and galactose residues. Biochemistry 40:8868\u20138876","journal-title":"Biochemistry"},{"key":"31_CR148","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/s10616-005-4537-x","volume":"50","author":"M Butler","year":"2006","unstructured":"Butler M (2006) Optimisation of the cellular metabolism of glycosylation for recombinant proteins produced by Mammalian cell systems. Cytotechnology 50:57\u201376","journal-title":"Cytotechnology"},{"key":"31_CR149","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3109\/10409239709085144","volume":"32","author":"PM Rudd","year":"1997","unstructured":"Rudd PM, Dwek RA (1997) Glycosylation: heterogeneity and the 3D structure of proteins. Crit Rev Biochem Mol Biol 32:1\u2013100","journal-title":"Crit Rev Biochem Mol Biol"},{"key":"31_CR150","doi-asserted-by":"publisher","first-page":"4269","DOI":"10.1016\/j.vaccine.2015.02.077","volume":"33","author":"S Kluge","year":"2015","unstructured":"Kluge S, Benndorf D, Genzel Y, Scharfenberg K, Rapp E, Reichl U (2015) Monitoring changes in proteome during stepwise adaptation of a MDCK cell line from adherence to growth in suspension. Vaccine 33:4269\u20134280","journal-title":"Vaccine"},{"key":"31_CR151","doi-asserted-by":"publisher","first-page":"6256","DOI":"10.1016\/j.vaccine.2010.07.004","volume":"28","author":"V Lohr","year":"2010","unstructured":"Lohr V, Genzel Y, Behrendt I, Scharfenberg K, Reichl U (2010) A new MDCK suspension line cultivated in a fully defined medium in stirred-tank and wave bioreactor. Vaccine 28:6256\u20136264","journal-title":"Vaccine"},{"key":"31_CR152","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1002\/bit.24834","volume":"110","author":"JV Roedig","year":"2013","unstructured":"Roedig JV, Rapp E, Bohne J, Kampe M, Kaffka H, Bock A, Genzel Y, Reichl U (2013) Impact of cultivation conditions on N-glycosylation of influenza virus a hemagglutinin produced in MDCK cell culture. Biotechnol Bioeng 110:1691\u20131703","journal-title":"Biotechnol Bioeng"},{"key":"31_CR153","doi-asserted-by":"publisher","first-page":"1776","DOI":"10.1016\/S0264-410X(03)00071-9","volume":"21","author":"C Gerdil","year":"2003","unstructured":"Gerdil C (2003) The annual production cycle for influenza vaccine. Vaccine 21:1776\u20131779","journal-title":"Vaccine"},{"key":"31_CR154","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1128\/JVI.06009-11","volume":"86","author":"S Murakami","year":"2012","unstructured":"Murakami S, Horimoto T, Ito M, Takano R, Katsura H, Shimojima M, Kawaoka Y (2012) Enhanced growth of influenza vaccine seed viruses in vero cells mediated by broadening the optimal pH range for virus membrane fusion. J Virol 86:1405\u20131410","journal-title":"J Virol"},{"key":"31_CR155","doi-asserted-by":"publisher","first-page":"8148","DOI":"10.1038\/ncomms9148","volume":"6","author":"J Ping","year":"2015","unstructured":"Ping J, Lopes TJ, Nidom CA, GHEDIN E, Macken CA, Fitch A, Imai M, Maher EA, Neumann G, Kawaoka Y (2015) Development of high-yield influenza A virus vaccine viruses. Nat Commun 6:8148","journal-title":"Nat Commun"},{"key":"31_CR156","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0011694","volume":"5","author":"JM Aguilar-Yanez","year":"2010","unstructured":"Aguilar-Yanez JM, Portillo-Lara R, Mendoza-Ochoa GI, Garcia-Echauri SA, Lopez-Pacheco F, Bulnes-Abundis D, Salgado-Gallegos J, Lara-Mayorga IM, Webb-Vargas Y, Leon-Angel FO, Rivero-Aranda RE, Oropeza-Almazan Y, Ruiz-Palacios GM, Zertuche-Guerra MI, Dubois RM, White SW, Schultz-Cherry S, Russell CJ, Alvarez MM (2010) An influenza A\/H1N1\/2009 hemagglutinin vaccine produced in Escherichia coli. PLoS One 5:e11694","journal-title":"PLoS One"},{"key":"31_CR157","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1002\/rmv.1980030206","volume":"3","author":"JS Robertson","year":"1993","unstructured":"Robertson JS (1993) Clinical influenza-virus and the embryonated Hen\u2019s egg. Rev Med Virol 3:97\u2013106","journal-title":"Rev Med Virol"},{"key":"31_CR158","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1371\/journal.pone.0027989","volume":"6","author":"JV Roedig","year":"2011","unstructured":"Roedig JV, Rapp E, Hoper D, Genzel Y, Reichl U (2011) Impact of host cell line adaptation on quasispecies composition and glycosylation of influenza A virus hemagglutinin. PLoS One 6:10","journal-title":"PLoS One"},{"key":"31_CR159","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0027989","volume":"6","author":"JV Roedig","year":"2011","unstructured":"Roedig JV, Rapp E, Hoper D, Genzel Y, Reichl U (2011) Impact of host cell line adaptation on quasispecies composition and glycosylation of influenza A virus hemagglutinin. PLoS One 6:e27989","journal-title":"PLoS One"},{"key":"31_CR160","doi-asserted-by":"publisher","first-page":"4027","DOI":"10.1074\/jbc.272.7.4027","volume":"272","author":"SY Mirshekari","year":"1997","unstructured":"Mirshekari SY, Ashford DA, Harvey DJ, Dwek RA, Schulze IT (1997) The glycosylation of the influenza A virus hemagglutinin by mammalian cells \u2013 a site-specific study. J Biol Chem 272:4027\u20134036","journal-title":"J Biol Chem"},{"key":"31_CR161","doi-asserted-by":"publisher","first-page":"4894","DOI":"10.1016\/S0021-9258(19)85580-1","volume":"255","author":"N Harpaz","year":"1980","unstructured":"Harpaz N, Schachter H (1980) Control of glycoprotein-synthesis. 5. Processing of asparagine-linked oligosaccharides by one or more rat-liver golgi alpha-D-mannosidases dependent on the prior action of UDP-N-acetylglucosamine-alpha-D-mannoside beta-2-N-acetylglucosaminyltransferase-I. J Biol Chem 255:4894\u20134902","journal-title":"J Biol Chem"},{"key":"31_CR162","unstructured":"Roedig JV (2014) Impact of cultivation conditions on N-glycosylation of influenza A virus hemagglutinin, on quasispecies composition, and on immunogenicity of virus preparations. PhD thesis, Otto von Guericke University, Magdeburg, Germany"}],"updated-by":[{"DOI":"10.1007\/10_2018_60","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2018,4,29]],"date-time":"2018-04-29T00:00:00Z","timestamp":1524960000000}},{"DOI":"10.1007\/10_2020_121","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2020,4,20]],"date-time":"2020-04-20T00:00:00Z","timestamp":1587340800000}}],"container-title":["Advances in Biochemical Engineering\/Biotechnology","Advances in Glycobiotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/10_2017_31","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,26]],"date-time":"2021-07-26T23:31:47Z","timestamp":1627342307000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/10_2017_31"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"ISBN":["9783030695897","9783030695903"],"references-count":162,"URL":"https:\/\/doi.org\/10.1007\/10_2017_31","relation":{"is-part-of":[{"id-type":"doi","id":"https:\/\/doi.org\/10.1007\/978-3-030-69590-3","asserted-by":"object"}]},"ISSN":["0724-6145","1616-8542"],"issn-type":[{"value":"0724-6145","type":"print"},{"value":"1616-8542","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017]]},"assertion":[{"value":"3 October 2017","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}